Key result
Slow release forms of verapamil, nifedipine, and amlodipine exerted comparable antihypertensive effects and did not significantly change muscle sympathetic nerve activity (P=NS).
Why the study?
Do amlodipine, nifedipine, or verapamil differ in their effects on muscle sympathetic nerve activity in patients with mild to moderate hypertension?
Population
43 patients (31 men, 12 women) with mild to moderate hypertension
Comparison
Amlodipine, nifedipine, or verapamil for 8 weeks vs Active comparators
Design
RCT, randomly assigned
Follow-up
8 weeks
Authors
Loading...
Supports interchangeable slow-release CCB selection in hypertension; confirms neutral MSNA effects across agents.
RCT (n=43)
randomly assigned
Do amlodipine, nifedipine, or verapamil differ in their effects on muscle sympathetic nerve activity in patients with mild to moderate hypertension?
p-value: p=NS
Slow release forms of verapamil, nifedipine, and amlodipine exert comparable antihypertensive effects and do not significantly change muscle sympathetic nerve activity in mild to moderate hypertension.
Binggeli et al. (2002) conducted an RCT in mild to moderate hypertension (n=43). Amlodipine, nifedipine, or verapamil vs. Active comparators was evaluated on muscle sympathetic nerve activity (MSA) (p=NS). Slow release forms of verapamil, nifedipine, and amlodipine exerted comparable antihypertensive effects and did not significantly change muscle sympathetic nerve activity (P=NS).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: